Toujeo Evidence

toujeo logo

Toujeo® is indicated for the treatment of diabetes mellitus in adults, adolescents and children from 6 years.

Switch HCP

Evidence of Toujeo in Adults with T1DM

There is a range of evidence for Toujeo in T1 Adults. Explore the evidence and view expert videos, clinical summaries and more!

Evidence of Toujeo in Children with T1DM

Toujeo is indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 6. Discover the evidence of Toujeo in children from 6-17 years and patient support materials suitable for them.

Evidence of Toujeo in Adults with T2DM

Explore the evidence in T2 with the BRIGHT study which is the only head-to-head randomised clinical trial comparing two 2nd generation basal insulins - Toujeo and insulin degludec 100 U/mL that met its primary endpoint.

This site uses cookies to store information on your computer. Some cookies on this site are needed because the site won’t work as expected without them. To learn more about cookies, please read our Cookie Policy.
By closing this message or using the website, you agree to our use of cookies on this device in agreement with our Cookie Policy, unless you have turned them off.
Accept and close